NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 125 filers reported holding NUVATION BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $38,765,581 | -24.3% | 13,275,884 | -5.7% | 28.72% | -13.1% |
| Q1 2024 | $51,223,318 | +125.1% | 14,072,340 | -6.6% | 33.04% | +79.2% |
| Q4 2023 | $22,759,233 | +12.7% | 15,072,340 | 0.0% | 18.44% | -0.6% |
| Q3 2023 | $20,196,936 | -25.6% | 15,072,340 | 0.0% | 18.55% | +22.0% |
| Q2 2023 | $27,130,212 | +8.4% | 15,072,340 | 0.0% | 15.20% | -6.9% |
| Q1 2023 | $25,020,084 | -13.5% | 15,072,340 | 0.0% | 16.32% | +67.3% |
| Q4 2022 | $28,938,893 | -14.3% | 15,072,340 | 0.0% | 9.75% | -21.1% |
| Q3 2022 | $33,762,000 | -31.7% | 15,072,340 | -1.1% | 12.36% | -21.6% |
| Q2 2022 | $49,401,000 | -59.1% | 15,247,340 | -33.6% | 15.77% | -36.2% |
| Q1 2022 | $120,756,000 | -38.1% | 22,957,340 | 0.0% | 24.71% | -10.4% |
| Q4 2021 | $195,137,000 | -30.4% | 22,957,340 | -18.6% | 27.59% | -12.3% |
| Q3 2021 | $280,431,000 | +6.8% | 28,212,376 | 0.0% | 31.46% | +5.8% |
| Q2 2021 | $262,657,000 | -10.9% | 28,212,376 | 0.0% | 29.73% | +6.6% |
| Q1 2021 | $294,819,000 | – | 28,212,376 | – | 27.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 15,247,340 | $49,401,000 | 15.77% |
| Aisling Capital Management LP | 2,541,009 | $8,233,000 | 5.87% |
| EDBI Pte Ltd | 1,270,504 | $4,116,000 | 3.82% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $3,684,000 | 3.36% |
| Deep Track Capital, LP | 11,471,281 | $37,167,000 | 2.44% |
| EcoR1 Capital, LLC | 13,896,543 | $45,025,000 | 1.55% |
| Boxer Capital, LLC | 4,341,009 | $14,065,000 | 0.89% |
| Baupost Group | 10,418,194 | $33,755,000 | 0.50% |
| Redmile Group, LLC | 3,471,709 | $11,248,000 | 0.43% |
| 683 Capital Management, LLC | 1,766,657 | $5,724,000 | 0.40% |